Univest
Univest
  • Markets
  • 3 Pathology and Radiology Chain, High-Volume Testing Lab and Single-Use Medical Devices Stocks With a Strong Future Roadmap: Vijaya Diagnostic Centre, Thyrocare Technologies and Poly Medicure

    • October 23, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Pathology and Radiology Chain, High-Volume Testing Lab and Single-Use Medical Devices Stocks With a Strong Future Roadmap: Vijaya Diagnostic Centre, Thyrocare Technologies and Poly Medicure

    Diagnostic Chain and Medical Consumables Stocks with a strong future roadmap: Vijaya Diagnostic Centre, Thyrocare Technologies and Poly Medicure. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.

    read more
  • 3 Multi-Specialty Hospital Network, Regional Hospital Group and Diagnostic Testing Network Stocks With a Strong Future Roadmap: Fortis Healthcare, Krishna Institute of Medical Sciences and Thyrocare Technologies

    • October 23, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Multi-Specialty Hospital Network, Regional Hospital Group and Diagnostic Testing Network Stocks With a Strong Future Roadmap: Fortis Healthcare, Krishna Institute of Medical Sciences and Thyrocare Technologies

    Hospital Network and Diagnostic Testing Stocks with a strong future roadmap: Fortis Healthcare, Krishna Institute of Medical Sciences and Thyrocare Technologies. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.

    read more
  • 3 Tertiary Care Hospitals, Preventive Health Testing and Large Hospital Chains Stocks With a Strong Future Roadmap: Global Health, Thyrocare Technologies and Apollo Hospitals Enterprise

    • October 22, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Tertiary Care Hospitals, Preventive Health Testing and Large Hospital Chains Stocks With a Strong Future Roadmap: Global Health, Thyrocare Technologies and Apollo Hospitals Enterprise

    Hospital and Preventive Diagnostics Stocks with a strong future roadmap: Global Health, Thyrocare Technologies and Apollo Hospitals Enterprise. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Metro Lab Network, Wellness Testing and Rapid Molecular Kits Stocks With a Strong Future Roadmap: Dr. Lal PathLabs, Thyrocare Technologies and Molbio Diagnostics

    • October 21, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Metro Lab Network, Wellness Testing and Rapid Molecular Kits Stocks With a Strong Future Roadmap: Dr. Lal PathLabs, Thyrocare Technologies and Molbio Diagnostics

    Pathology and Testing Stocks with a strong future roadmap: Dr. Lal PathLabs, Thyrocare Technologies and Molbio Diagnostics. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more
  • 3 Hospital Network, Cardiac Care and Preventive Testing Stocks With a Strong Future Roadmap: Max Healthcare Institute, Narayana Hrudayalaya and Thyrocare Technologies

    • October 21, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Hospital Network, Cardiac Care and Preventive Testing Stocks With a Strong Future Roadmap: Max Healthcare Institute, Narayana Hrudayalaya and Thyrocare Technologies

    Private Healthcare Stocks with a strong future roadmap: Max Healthcare Institute, Narayana Hrudayalaya and Thyrocare Technologies. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more
  • 3 Niche Healthcare Service Stocks With a Strong Future Roadmap: Thyrocare Technologies, Jeena Sikho Lifecare and Rainbow Children’s Medicare

    • October 7, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Niche Healthcare Service Stocks With a Strong Future Roadmap: Thyrocare Technologies, Jeena Sikho Lifecare and Rainbow Children's Medicare

    Thyrocare Technologies, Jeena Sikho Lifecare and Rainbow Children’s Medicare compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more